Trials / Unknown
UnknownNCT06076070
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Regina Elena Cancer Institute · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Multicenter noninterventional, translational study, retrospective/prospective designed in order to assess the aptitude to the use of genomic profiling methods for therapeutic purposes and evaluation by the institutional Molecular Tumor Board (MTB) of sarcoma patients with metastatic/locally advanced disease that is inoperable with no viable therapeutic alternatives or with histotypes known to be resistant to available in-label medical treatments and without already therapeutically validated driver mutations.
Conditions
Timeline
- Start date
- 2022-05-25
- Primary completion
- 2024-05-25
- Completion
- 2024-05-25
- First posted
- 2023-10-10
- Last updated
- 2023-10-10
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06076070. Inclusion in this directory is not an endorsement.